Handelsbanken Fonder Ab Qiagen N.V. Transaction History

Handelsbanken Fonder Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$43.93 - $46.76 $369,012 - $392,784	8,400 Added 24.14%	43,200 $1.95 Million
Q1 2023 Apr 28, 2023	BUY	$45.29 - $50.76 $135,870 - $152,280	3,000 Added 9.43%	34,800 $1.6 Million
Q2 2022 Aug 03, 2022	BUY	$42.98 - $49.77 $51,575 - $59,724	1,200 Added 3.92%	31,800 $1.5 Million
Q1 2022 May 11, 2022	SELL	$42.23 - $54.3 $291,387 - $374,670	-6,900 Reduced 18.4%	30,600 $1.5 Million
Q4 2021 Feb 08, 2022	SELL	$50.62 - $56.47 $323,968 - $361,408	-6,400 Reduced 14.58%	37,500 $2.08 Million

Q3 2021 Nov 10, 2021	BUY	$46.55 - $56.83 $246,714 - $301,199	5,300 Added 13.73%	43,900 $2.27 Million
Q2 2021 Aug 03, 2021	SELL	$46.28 - $52.75 $120,328 - $137,150	-2,600 Reduced 6.31%	38,600 $1.87 Million
Q2 2020 Aug 26, 2020	BUY	$39.49 - $44.36 $1.63 Million - $1.83 Million	41,200 New	41,200 $1.76 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.24B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.